With U.S. Funding Faltering, Europe May Be the Next Hub for Life Sciences Innovation
In the wake of NIH cuts and IPO slowdowns, Europe offers what the U.S. can’t right now: stability and scale.
Welcome to the latest edition from FemmeHealth Ventures Alliance — delivering strategic insights into women’s health innovation and investment. We help you track emerging opportunities in Femtech and beyond, through a disciplined investor lens.
Keep reading with a 7-day free trial
Subscribe to The Billion Dollar Blindspot to keep reading this post and get 7 days of free access to the full post archives.